Behaviour of the typhoid vaccine intradermally administered in association with tetanus unadsorbed vaccine and soluble antigens of vaccinia virus.
Croitoru
M
M
Dimache
G
G
Mihăilescu
R
R
Velea
V
V
Durbacă
S
S
Stoean
C
C
D000293:Adolescent; D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000008:administration & dosage* / Q000276:immunology / Q000633:toxicity; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D051379:Mice; D012995:Solubility; D013745:Tetanus Toxoid / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D014436:Typhoid-Paratyphoid Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D014616:Vaccinia virus / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D013745:Tetanus Toxoid; D014436:Typhoid-Paratyphoid Vaccines